美国在新冠疫情期间的糖尿病护理和血糖控制。
Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States.
机构信息
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
出版信息
JAMA Intern Med. 2021 Oct 1;181(10):1412-1414. doi: 10.1001/jamainternmed.2021.3047.
Abstract
This cohort study compares rates at which patients with type 2 diabetes received diabetes-related health services prior to and during the COVID-19 pandemic.
摘要
这项队列研究比较了 2 型糖尿病患者在 COVID-19 大流行之前和期间接受与糖尿病相关的医疗服务的比率。
相似文献
1
Diabetes Care and Glycemic Control During the COVID-19 Pandemic in the United States.美国在新冠疫情期间的糖尿病护理和血糖控制。
JAMA Intern Med. 2021 Oct 1;181(10):1412-1414. doi: 10.1001/jamainternmed.2021.3047.
2
The Impact of Telemedicine-Augmented Integrated Personalized Diabetes Management on Glycemic Control in Adults With Diabetes Mellitus During the COVID-19 Pandemic: A Retrospective Study.远程医疗增强型综合个性化糖尿病管理对2019年冠状病毒病大流行期间成年糖尿病患者血糖控制的影响：一项回顾性研究
Asia Pac J Public Health. 2023 Mar;35(2-3):194-196. doi: 10.1177/10105395231158458. Epub 2023 Feb 24.
3
Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.新型冠状病毒肺炎大流行对行为改变和血糖控制的影响及糖尿病患者远程医疗调查：一项多中心回顾性观察研究。
J Diabetes Investig. 2023 Aug;14(8):994-1004. doi: 10.1111/jdi.14027. Epub 2023 May 15.
4
Diabetes and Technology in the Covid-19 Pandemic Crisis.2019冠状病毒病大流行危机中的糖尿病与技术
J Diabetes Sci Technol. 2021 Mar;15(2):377-378. doi: 10.1177/1932296820929385. Epub 2020 May 27.
5
Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders.新冠疫情居家令期间远程医疗用于糖尿病专科护理的差异
J Diabetes Sci Technol. 2021 Sep;15(5):986-992. doi: 10.1177/1932296821997851. Epub 2021 Mar 14.
6
Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range.实时连续血糖监测在 2019 冠状病毒病大流行期间及其对达标时间的影响。
Diabetes Technol Ther. 2021 Mar;23(S1):S1-S7. doi: 10.1089/dia.2020.0649.
7
The Effects of Paternalistic Policies During COVID-19 on Vulnerable Populations.新冠疫情期间家长式政策对弱势群体的影响。
J Natl Med Assoc. 2021 Jun;113(3):294-296. doi: 10.1016/j.jnma.2020.11.013. Epub 2021 Jan 19.
8
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.在 COVID-19 大流行期间，通过远程医疗对意大利的 1 型糖尿病儿童和青少年进行随访，改善血糖控制。
Front Endocrinol (Lausanne). 2020 Dec 7;11:595735. doi: 10.3389/fendo.2020.595735. eCollection 2020.
9
Adjuvant therapy in type 1 diabetes mellitus - choice or necessity in the COVID-19 pandemic?1型糖尿病的辅助治疗——在新冠疫情期间是选择还是必要措施？
Endokrynol Pol. 2021;72(2):89-90. doi: 10.5603/EP.a2021.0022.
10
Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: What comes after a "quarantine"?1 型糖尿病患者的血糖控制与 COVID-19 封锁：“隔离”之后会发生什么？
J Diabetes. 2020 Dec;12(12):946-948. doi: 10.1111/1753-0407.13110. Epub 2020 Oct 2.
引用本文的文献
1
What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.社会结构变化对糖尿病自我管理及糖化血红蛋白（HbA1c）变化轨迹有何影响？一项针对门诊治疗的糖尿病患者在2019冠状病毒病大流行之前、期间及之后的队列研究。
PLoS One. 2025 Aug 12;20(8):e0329394. doi: 10.1371/journal.pone.0329394. eCollection 2025.
2
Healthcare Resource Utilization and Costs in Individuals Who Discontinue Liraglutide and Who Switch from Liraglutide to Once-Weekly Injectable Semaglutide.停用利拉鲁肽以及从利拉鲁肽转换为每周一次注射用司美格鲁肽的个体的医疗资源利用和成本
Diabetes Ther. 2025 May 16. doi: 10.1007/s13300-025-01741-8.
3
Diabetes prevalence, awareness, and control in the United States, 2017-2023.2017 - 2023年美国糖尿病的患病率、知晓率及控制情况
Diabetes Metab. 2025 Jul;51(4):101659. doi: 10.1016/j.diabet.2025.101659. Epub 2025 May 13.
4
COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: A retrospective study in the United Kingdom.2019冠状病毒病大流行与心肾代谢疾病患者的风险因素测量：英国的一项回顾性研究
PLoS One. 2025 Apr 24;20(4):e0319438. doi: 10.1371/journal.pone.0319438. eCollection 2025.
5
Patient and Clinician Perspectives on the Effectiveness of Current Telemedicine Approaches in Endocrinology Care for Type 2 Diabetes: Qualitative Study.患者与临床医生对当前远程医疗方法在2型糖尿病内分泌护理中有效性的看法：定性研究
JMIR Diabetes. 2025 Mar 11;10:e60765. doi: 10.2196/60765.
6
Antidiabetic Medicines Utilisation During Pre-Pandemic, Pandemic and Post-Pandemic Period of COVID-19-Data for Bulgarian Population.2019冠状病毒病大流行前、大流行期间和大流行后保加利亚人群使用抗糖尿病药物的数据。
Healthcare (Basel). 2025 Feb 4;13(3):322. doi: 10.3390/healthcare13030322.
7
Severe Insulin Pump-Related Adverse Events: Potential Root Causes and Impact of the COVID-19 Pandemic.严重的胰岛素泵相关不良事件：潜在根本原因及新冠疫情的影响
J Diabetes Sci Technol. 2024 May 28:19322968241254521. doi: 10.1177/19322968241254521.
8
Comparative Analysis of COVID-19 Outcomes in Type 1 and Type 2 Diabetes: A Three-Year Retrospective Study.1 型和 2 型糖尿病患者 COVID-19 结局的对比分析：一项为期三年的回顾性研究。
Medicina (Kaunas). 2024 Jan 25;60(2):210. doi: 10.3390/medicina60020210.
9
Trends in Use of Telemedicine for Stimulant Initiation Among Children and Adults.儿童和成人中使用远程医疗启动兴奋剂的趋势。
Psychiatr Serv. 2024 Jul 1;75(7):630-637. doi: 10.1176/appi.ps.20230421. Epub 2024 Jan 19.
10
The Implications of the Pandemic with Covid-19 in the Glycemic Control of People with Type 2 Diabetes.2019年冠状病毒病疫情对2型糖尿病患者血糖控制的影响
Diabetes Metab Syndr Obes. 2023 Dec 15;16:4109-4118. doi: 10.2147/DMSO.S434990. eCollection 2023.
Zotero 插件